Selected research
Market Analysis & Forecast
Global Parenteral Nutrition Products Market Analysis and Forecast 2026-2032
Market perspective
The global Parenteral Nutrition Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Parenteral Nutrition Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Parenteral Nutrition Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Parenteral Nutrition Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Parenteral Nutrition Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Parenteral Nutrition Products include Teva Pharmaceutical, Sichuan Kelun Pharmaceutical, Pfizer, B. Braun Melsungen, Baxter International, Otsuka Pharmaceutical, Grifols International and Fresenius Kabi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Parenteral Nutrition Products, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Parenteral Nutrition Products, also provides the sales of main regions and countries. Of the upcoming market potential for Parenteral Nutrition Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Parenteral Nutrition Products sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Parenteral Nutrition Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Parenteral Nutrition Products sales, projected growth trends, production technology, application and end-user industry.
Parenteral Nutrition Products Segment by Company
Teva Pharmaceutical
Sichuan Kelun Pharmaceutical
Pfizer
B. Braun Melsungen
Baxter International
Otsuka Pharmaceutical
Grifols International
Fresenius Kabi
Parenteral Nutrition Products Segment by Type
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Carbohydrates
Trace Elements
Vitamins and Minerals
Parenteral Nutrition Products Segment by Application
Premature Infants, Neonates and Children
Chronic Disease Patients
Geriatrics
Parenteral Nutrition Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Nutrition Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parenteral Nutrition Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Nutrition Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Parenteral Nutrition Products in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Parenteral Nutrition Products manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parenteral Nutrition Products sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solution
- Carbohydrates
- Trace Elements
- Vitamins and Minerals
Applications
- Premature Infants, Neonates and Children
- Chronic Disease Patients
- Geriatrics
Companies covered
- Teva Pharmaceutical
- Sichuan Kelun Pharmaceutical
- Pfizer
- B. Braun Melsungen
- Baxter International
- Otsuka Pharmaceutical
- Grifols International
- Fresenius Kabi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Parenteral Nutrition Products Market by Type
- 1.2.1 Global Parenteral Nutrition Products Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Parenteral Lipid Emulsion
- 1.2.3 Single Dose Amino Acid Solution
- 1.2.4 Carbohydrates
- 1.2.5 Trace Elements
- 1.2.6 Vitamins and Minerals
- 1.3 Parenteral Nutrition Products Market by Application
- 1.3.1 Global Parenteral Nutrition Products Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Premature Infants, Neonates and Children
- 1.3.3 Chronic Disease Patients
- 1.3.4 Geriatrics
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Parenteral Nutrition Products Market Dynamics
- 2.1 Parenteral Nutrition Products Industry Trends
- 2.2 Parenteral Nutrition Products Industry Drivers
- 2.3 Parenteral Nutrition Products Industry Opportunities and Challenges
- 2.4 Parenteral Nutrition Products Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Parenteral Nutrition Products Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Parenteral Nutrition Products Revenue by Region
- 3.2.1 Global Parenteral Nutrition Products Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Parenteral Nutrition Products Revenue by Region (2021-2026)
- 3.2.3 Global Parenteral Nutrition Products Revenue by Region (2027-2032)
- 3.2.4 Global Parenteral Nutrition Products Revenue Market Share by Region (2021-2032)
- 3.3 Global Parenteral Nutrition Products Sales Estimates and Forecasts 2021-2032
- 3.4 Global Parenteral Nutrition Products Sales by Region
- 3.4.1 Global Parenteral Nutrition Products Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Parenteral Nutrition Products Sales by Region (2021-2026)
- 3.4.3 Global Parenteral Nutrition Products Sales by Region (2027-2032)
- 3.4.4 Global Parenteral Nutrition Products Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Parenteral Nutrition Products Revenue by Manufacturers
- 4.1.1 Global Parenteral Nutrition Products Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Parenteral Nutrition Products Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Parenteral Nutrition Products Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Parenteral Nutrition Products Sales by Manufacturers
- 4.2.1 Global Parenteral Nutrition Products Sales by Manufacturers (2021-2026)
- 4.2.2 Global Parenteral Nutrition Products Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Parenteral Nutrition Products Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Parenteral Nutrition Products Sales Price by Manufacturers (2021-2026)
- 4.4 Global Parenteral Nutrition Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Parenteral Nutrition Products Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Parenteral Nutrition Products Manufacturers, Product Type & Application
- 4.7 Global Parenteral Nutrition Products Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Parenteral Nutrition Products Market CR5 and HHI
- 4.8.2 2025 Parenteral Nutrition Products Tier 1, Tier 2, and Tier 3
5 Parenteral Nutrition Products Market by Type
- 5.1 Global Parenteral Nutrition Products Revenue by Type
- 5.1.1 Global Parenteral Nutrition Products Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Parenteral Nutrition Products Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Parenteral Nutrition Products Revenue Market Share by Type (2021-2032)
- 5.2 Global Parenteral Nutrition Products Sales by Type
- 5.2.1 Global Parenteral Nutrition Products Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Parenteral Nutrition Products Sales by Type (2021-2032) & (W Units)
- 5.2.3 Global Parenteral Nutrition Products Sales Market Share by Type (2021-2032)
- 5.3 Global Parenteral Nutrition Products Price by Type
6 Parenteral Nutrition Products Market by Application
- 6.1 Global Parenteral Nutrition Products Revenue by Application
- 6.1.1 Global Parenteral Nutrition Products Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Parenteral Nutrition Products Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Parenteral Nutrition Products Revenue Market Share by Application (2021-2032)
- 6.2 Global Parenteral Nutrition Products Sales by Application
- 6.2.1 Global Parenteral Nutrition Products Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Parenteral Nutrition Products Sales by Application (2021-2032) & (W Units)
- 6.2.3 Global Parenteral Nutrition Products Sales Market Share by Application (2021-2032)
- 6.3 Global Parenteral Nutrition Products Price by Application
7 Company Profiles
- 7.1 Teva Pharmaceutical
- 7.1.1 Teva Pharmaceutical Company Information
- 7.1.2 Teva Pharmaceutical Business Overview
- 7.1.3 Teva Pharmaceutical Parenteral Nutrition Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Teva Pharmaceutical Parenteral Nutrition Products Product Portfolio
- 7.1.5 Teva Pharmaceutical Recent Developments
- 7.2 Sichuan Kelun Pharmaceutical
- 7.2.1 Sichuan Kelun Pharmaceutical Company Information
- 7.2.2 Sichuan Kelun Pharmaceutical Business Overview
- 7.2.3 Sichuan Kelun Pharmaceutical Parenteral Nutrition Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Sichuan Kelun Pharmaceutical Parenteral Nutrition Products Product Portfolio
- 7.2.5 Sichuan Kelun Pharmaceutical Recent Developments
- 7.3 Pfizer
- 7.3.1 Pfizer Company Information
- 7.3.2 Pfizer Business Overview
- 7.3.3 Pfizer Parenteral Nutrition Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Pfizer Parenteral Nutrition Products Product Portfolio
- 7.3.5 Pfizer Recent Developments
- 7.4 B. Braun Melsungen
- 7.4.1 B. Braun Melsungen Company Information
- 7.4.2 B. Braun Melsungen Business Overview
- 7.4.3 B. Braun Melsungen Parenteral Nutrition Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 B. Braun Melsungen Parenteral Nutrition Products Product Portfolio
- 7.4.5 B. Braun Melsungen Recent Developments
- 7.5 Baxter International
- 7.5.1 Baxter International Company Information
- 7.5.2 Baxter International Business Overview
- 7.5.3 Baxter International Parenteral Nutrition Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Baxter International Parenteral Nutrition Products Product Portfolio
- 7.5.5 Baxter International Recent Developments
- 7.6 Otsuka Pharmaceutical
- 7.6.1 Otsuka Pharmaceutical Company Information
- 7.6.2 Otsuka Pharmaceutical Business Overview
- 7.6.3 Otsuka Pharmaceutical Parenteral Nutrition Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Otsuka Pharmaceutical Parenteral Nutrition Products Product Portfolio
- 7.6.5 Otsuka Pharmaceutical Recent Developments
- 7.7 Grifols International
- 7.7.1 Grifols International Company Information
- 7.7.2 Grifols International Business Overview
- 7.7.3 Grifols International Parenteral Nutrition Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Grifols International Parenteral Nutrition Products Product Portfolio
- 7.7.5 Grifols International Recent Developments
- 7.8 Fresenius Kabi
- 7.8.1 Fresenius Kabi Company Information
- 7.8.2 Fresenius Kabi Business Overview
- 7.8.3 Fresenius Kabi Parenteral Nutrition Products Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Fresenius Kabi Parenteral Nutrition Products Product Portfolio
- 7.8.5 Fresenius Kabi Recent Developments
8 North America
- 8.1 North America Parenteral Nutrition Products Market Size by Type
- 8.1.1 North America Parenteral Nutrition Products Revenue by Type (2021-2032)
- 8.1.2 North America Parenteral Nutrition Products Sales by Type (2021-2032)
- 8.1.3 North America Parenteral Nutrition Products Price by Type (2021-2032)
- 8.2 North America Parenteral Nutrition Products Market Size by Application
- 8.2.1 North America Parenteral Nutrition Products Revenue by Application (2021-2032)
- 8.2.2 North America Parenteral Nutrition Products Sales by Application (2021-2032)
- 8.2.3 North America Parenteral Nutrition Products Price by Application (2021-2032)
- 8.3 North America Parenteral Nutrition Products Market Size by Country
- 8.3.1 North America Parenteral Nutrition Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Parenteral Nutrition Products Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Parenteral Nutrition Products Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Parenteral Nutrition Products Market Size by Type
- 9.1.1 Europe Parenteral Nutrition Products Revenue by Type (2021-2032)
- 9.1.2 Europe Parenteral Nutrition Products Sales by Type (2021-2032)
- 9.1.3 Europe Parenteral Nutrition Products Price by Type (2021-2032)
- 9.2 Europe Parenteral Nutrition Products Market Size by Application
- 9.2.1 Europe Parenteral Nutrition Products Revenue by Application (2021-2032)
- 9.2.2 Europe Parenteral Nutrition Products Sales by Application (2021-2032)
- 9.2.3 Europe Parenteral Nutrition Products Price by Application (2021-2032)
- 9.3 Europe Parenteral Nutrition Products Market Size by Country
- 9.3.1 Europe Parenteral Nutrition Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Parenteral Nutrition Products Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Parenteral Nutrition Products Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Parenteral Nutrition Products Market Size by Type
- 10.1.1 China Parenteral Nutrition Products Revenue by Type (2021-2032)
- 10.1.2 China Parenteral Nutrition Products Sales by Type (2021-2032)
- 10.1.3 China Parenteral Nutrition Products Price by Type (2021-2032)
- 10.2 China Parenteral Nutrition Products Market Size by Application
- 10.2.1 China Parenteral Nutrition Products Revenue by Application (2021-2032)
- 10.2.2 China Parenteral Nutrition Products Sales by Application (2021-2032)
- 10.2.3 China Parenteral Nutrition Products Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Parenteral Nutrition Products Market Size by Type
- 11.1.1 Asia Parenteral Nutrition Products Revenue by Type (2021-2032)
- 11.1.2 Asia Parenteral Nutrition Products Sales by Type (2021-2032)
- 11.1.3 Asia Parenteral Nutrition Products Price by Type (2021-2032)
- 11.2 Asia Parenteral Nutrition Products Market Size by Application
- 11.2.1 Asia Parenteral Nutrition Products Revenue by Application (2021-2032)
- 11.2.2 Asia Parenteral Nutrition Products Sales by Application (2021-2032)
- 11.2.3 Asia Parenteral Nutrition Products Price by Application (2021-2032)
- 11.3 Asia Parenteral Nutrition Products Market Size by Country
- 11.3.1 Asia Parenteral Nutrition Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Parenteral Nutrition Products Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Parenteral Nutrition Products Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Parenteral Nutrition Products Market Size by Type
- 12.1.1 SAMEA Parenteral Nutrition Products Revenue by Type (2021-2032)
- 12.1.2 SAMEA Parenteral Nutrition Products Sales by Type (2021-2032)
- 12.1.3 SAMEA Parenteral Nutrition Products Price by Type (2021-2032)
- 12.2 SAMEA Parenteral Nutrition Products Market Size by Application
- 12.2.1 SAMEA Parenteral Nutrition Products Revenue by Application (2021-2032)
- 12.2.2 SAMEA Parenteral Nutrition Products Sales by Application (2021-2032)
- 12.2.3 SAMEA Parenteral Nutrition Products Price by Application (2021-2032)
- 12.3 SAMEA Parenteral Nutrition Products Market Size by Country
- 12.3.1 SAMEA Parenteral Nutrition Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Parenteral Nutrition Products Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Parenteral Nutrition Products Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Parenteral Nutrition Products Value Chain Analysis
- 13.1.1 Parenteral Nutrition Products Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Parenteral Nutrition Products Production Mode & Process
- 13.2 Parenteral Nutrition Products Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Parenteral Nutrition Products Distributors
- 13.2.3 Parenteral Nutrition Products Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst